| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Novavax Inc (NVAX) has 8 insiders with recent SEC Form 4 filings, including 11 buys and 2 sells. NVAX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 264.1K | $2.38M | - | |
| CFO | 145.1K | $1.31M | - | |
| VP | 112.7K | $1.01M | - | |
| VP | 34.9K | $313.9K | - | |
| Dir | 28.5K | $256.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 13, 2019 | Glenn Gregory M88 | President, R&D | Sell | 9,620 | $6.18 | $59,475.65 | -98.7% | |
| Sep 11, 2019 | Trizzino John86 | SVP, Cbo And CFO | Sell | 5,578 | $5.72 | $31,911.18 | -53.7% | |
| May 13, 2019 | Glenn Gregory M88 | President, R&D | Buy | 1,000 | $5.85 | $5,849.90 | +1.4% | |
| Mar 27, 2019 | King Rachel K. | Director | Buy | 86,000 | $0.53 | $45,562.80 | New | |
| Jan 31, 2019 | Glenn Gregory M88 | President, R&D | Buy | 13,168 | $0.88 | $11,587.84 | +21.9% | |
| Jul 31, 2018 | Glenn Gregory M88 | President, R&D | Buy | 13,007 | $0.88 | $11,446.16 | +27.6% | |
| May 14, 2018 | Glenn Gregory M88 | President, R&D | Buy | 20,000 | $1.64 | $32,799.50 | +36.7% | |
| May 14, 2018 | Trizzino John86 | SVP, Cbo And CFO | Buy | 50,000 | $1.64 | $81,995.00 | +56.2% | |
| May 14, 2018 | Erck Stanley C86 | President And CEO | Buy | 100,000 | $1.65 | $164,620.00 | +43.8% | |
| Jan 31, 2018 | Glenn Gregory M88 | President, R&D | Buy | 12,784 | $0.88 | $11,249.92 | +88.6% |